Tuebingen

Toni Weinschenk

This inventor holds 1 USPTO granted patent. Top assignee: Immatics Biotechnologies Gmbh. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toni Weinschenk. Retrieved from https://idiyas.com/inventor/toni-weinschenk-6dwepb22

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Toni Weinschenk in Immunotherapy

Introduction

Toni Weinschenk is a notable inventor based in Tuebingen, recognized for his contributions to the field of immunotherapy. His work focuses on developing innovative solutions to combat cancer through the use of peptides.

Latest Patents

Weinschenk holds a patent titled "Peptides and Combination of Peptides for Use in Immunotherapy Against Cancers." This patent represents a significant advancement in cancer treatment, showcasing his commitment to improving patient outcomes.

Career Highlights

Toni Weinschenk is associated with Immatics Biotechnologies GmbH, a company dedicated to developing innovative immunotherapies. His role at Immatics highlights his expertise and dedication to advancing cancer treatment through scientific research.

Collaborations

Weinschenk collaborates with talented professionals such as Oliver Schoor and Andrea Mahr, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Toni Weinschenk's work in immunotherapy exemplifies the impact of innovative thinking in the fight against cancer. His contributions through patents and collaboration with esteemed colleagues continue to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…